Dan Hussar was feeling fine after treatment for acute myeloid leukemia (AML). But when some unusual bumps on his skin turned out to be an AML relapse, the Philadelphia resident and pharmacy professor began to feel discouraged by his lack of options. That’s when Dan’s doctor suggested a clinical trial at Memorial Sloan Kettering. The trial was targeted to specific mutations found in Dan’s tumor, and the results seemed promising.
Jason Brown sensed something wasn’t right. A swollen lymph node in his neck hadn’t gone down even after treatment with antibiotics. Soon after, the 46-year-old was diagnosed with HPV-associated oropharyngeal cancer. Memorial Sloan Kettering experts used proton therapy to treat his tumor with limited side effects.